Vaccination coverage of influenza and pneumococcal vaccines in patients with rheumatic diseases: a systematic review and meta-analysis
Clicks: 1
ID: 319559
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #193 of 202 articles by views in Lara D. Veeken
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 202 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
OBJECTIVES: Current guidelines recommend influenza and pneumococcal vaccination in the majority of patients with rheumatic diseases. This study aimed to summarize the coverage of influenza and pneumococcal vaccines among these patients. METHODS: A literature search was conducted in PubMed, Embase, Web of Science and Scopus for eligible studies. Vaccination rate was presented as a percentage with 95% confidence intervals (CI). Clinical characteristics of the vaccinated patients were shown as the mean difference (MD) or odds ratio (OR) with 95% CI. Sensitivity analyses, subgroup analyses and meta-regression were performed to identify sources of heterogeneity. RESULTS: A total of 51 studies were identified. The pooled vaccination rates of influenza vaccine in patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), spondylarthritis (SpA) and psoriasis arthritis (PsA) were 50%, 42%, 43% and 53%, respectively. The corresponding rates of pneumococcal vaccination in patients were 37%, 30%, 39% and 41%, respectively. Compared with unvaccinated RA patients, vaccinated RA patients were associated with older age and an increased prevalence of comorbidities. Geographical location and use of disease-modifying antirheumatic drugs were two significant factors affecting the heterogeneity of the study results. A larger proportion of patients received vaccine education from rheumatologists rather than general practitioners, and the two major reasons for not receiving vaccination were "lack of awareness" and "not offered by doctors". CONCLUSION: Influenza and pneumococcal vaccine coverage was still suboptimal in patients with rheumatic diseases. Enhancing vaccine education from physicians and improving awareness of patients may become two important approaches to improve vaccination rates.
| Reference Key |
openalex_W7167241062
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Dongru Du, T Zeng, Jiangyue Qin, L Gao, J Y Xiong, F Luo, Yongchun Shen |
| Journal | Lara D. Veeken |
| Year | 2026 |
| DOI |
10.1093/rheumatology/keag352
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.